1
Conservative Management of CIN2 Lesions and Biomarkers Evaluation
Condition(s):CIN2Last Updated:December 30, 2020Recruiting
CIN2: 186 Clinical Trials, Page 1 of 19
Hide Studies Not Open or Pending
2
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
Condition(s):HPV Infection; Cervical CancerLast Updated:September 11, 2020Recruiting
3
Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3; High-risk HPV (Any Strain)Last Updated:May 29, 2019Completed
4
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 – 30 Years of Age
Condition(s):CIN2; TherapyLast Updated:April 4, 2019Recruiting
5
Management of Cervical Intraepithelial Neoplasia Grade 2
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:January 11, 2010Completed
6
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Condition(s):HPV16 Positive; Cervical Intraepithelial Neoplasia (CIN 2/3)Last Updated:July 9, 2018Completed
7
A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3Last Updated:February 7, 2020Recruiting
8
Prognostic Value of Human Papillomavirus (HPV) Detection in Cervical Intra-epithelial Neoplasia (CIN) Recurrence After Conization
Condition(s):CIN2/3 RecurrenceLast Updated:August 24, 2017Terminated
9
HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women
Condition(s):HIV-1 InfectionLast Updated:May 11, 2018Completed
10
The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3Last Updated:December 8, 2017Unknown status